N-[(3-bromo-4-cyanophenyl)methyl]-4-cyano-N-[(3-methylimidazol-4-yl)methyl]-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-1-carboxamide

InChIKey	`XCKIUXVZLPDAPE-UHFFFAOYSA-N`
Compound Name	N-[(3-bromo-4-cyanophenyl)methyl]-4-cyano-N-[(3-methylimidazol-4-yl)methyl]-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-1-carboxamide
Canonical SMILES	`Cn1cncc1CN(Cc1ccc(C#N)c(Br)c1)C(=O)N1CCC(C#N)=C(c2cccc3ccccc23)C1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	8.51
Source	ChEMBL;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P49354	FNTA	Homo sapiens	Human	PF01239	8.5	pIC50	TTD_MultiTarget
P49356	FNTB	Homo sapiens	Human	PF00432	8.5	IC50	ChEMBL